Swiss Heart Foundation
17
2
2
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
11.8%
2 terminated/withdrawn out of 17 trials
85.7%
-0.8% vs industry average
24%
4 trials in Phase 3/4
0%
0 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque
Role: collaborator
Colchicine After Electrocardioversion for Atrial Fibrillation
Role: collaborator
International Intracranial Dissection Study
Role: collaborator
Early Minimally Invasive Image Guided Endoscopic Evacuation of Intracerebral Haemorrhage
Role: collaborator
Health Consequences of the Burden of Atrial Fibrillation
Role: collaborator
Cascade Genetic Testing of Familial Hypercholesterolemia
Role: collaborator
Novel Oral Anticoagulants in Stroke Patients
Role: collaborator
Sleep Deficiency and Stroke Outcome
Role: collaborator
ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART
Role: collaborator
Gait Adaptation for Stroke Patients With Augmented Reality
Role: collaborator
Brain-heart Interactions in Tako-Tsubo Cardiomyopathy and Cardiac Syndrome X:
Role: collaborator
Swiss Intravenous and Intra-arterial Thrombolysis for Treatment of Acute Ischemic Stroke Registry
Role: collaborator
Filgrastim for the Promotion of Collateral Growth in Patients With CAD
Role: collaborator
Carotid Plaque Screening Trial in Smokers
Role: collaborator
Assessment of Natural Bypasses in the Lower Limb
Role: collaborator
Absolute Myocardial Perfusion Measurement in the Transplanted Heart
Role: collaborator
Angioplasty in Peripheral Arterial Disease and Endothelial Function
Role: collaborator
All 17 trials loaded